Skip to main content
Log in

Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis

  • Original Paper
  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

In a standard situation, a quantitative systems pharmacology model describes a “reference patient,” and the model parameters are fixed values allowing only the mean values to be described. However, the results of clinical trials include a description of variability in patients’ responses to a drug, which is typically expressed in terms of conventional statistical parameters, such as standard deviations (SDs) from mean values. Therefore, in this study, we propose and compare four different approaches: (1) Monte Carlo Markov Chain (MCMC); (2) model fitting to Monte Carlo sample; (3) population of clones; (4) stochastically bounded selection to generate virtual patient populations based on experimentally measured mean data and SDs. We applied these approaches to generate virtual patient populations in the QSP model of erythropoiesis. According to the results of our research, stochastically bounded selection showed slightly better results than the other three methods as it allowed the description of any number of patients from clinical trials and could be applied in the case of complex models with a large number of variable parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Notes

  1. The Human normal erythropoiesys stimulated by ESA model is available at https://shiny.insysbio.com/ery/#!/. Prepared by Evgeny Metelkin, Alexander Stepanov (2019)

  2. Data taken from Fig. 7

References

  1. Chien JY, Friedrich S, Heathman MA, de Alwis DP, Sinha V (2005) Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation. The AAPS J. https://doi.org/10.1208/aapsj070355

    Article  PubMed  Google Scholar 

  2. Knight-Schrijver VR, Chelliah V, Cucurull-Sanchez L, Le Novère N (2016) The promises of quantitative systems pharmacology modelling for drug development. Comput Str Biotechnol J. https://doi.org/10.1016/j.csbj.2016.09.002

    Article  Google Scholar 

  3. Bloomingdale P, Karelina T, Cirit M, Muldoon SF, Baker J, McCarty WJ, Geerts H, Macha S (2021) Quantitative systems pharmacology in neuroscience: novel methodologies and technologies. CPT. https://doi.org/10.1002/psp4.12607

    Article  Google Scholar 

  4. Chelliah V, Lazarou G, Bhatnagar S et al (2020) Quantitative systems pharmacology approaches for immuno-oncology: adding virtual patients to the development paradigm. Clinic Pharmacol Ther. https://doi.org/10.1002/cpt.1987

    Article  Google Scholar 

  5. Dai W, Rao R, Sher A, Tania N, Musante CJ, Allen R (2020) A prototype qsp model of the immune response to SARS-CoV-2 for community development. CPT. https://doi.org/10.1002/psp4.12574

    Article  Google Scholar 

  6. Balbas-Martinez V, Asin-Prieto E, Parra-Guillen ZP, Troconiz IF (2020) A quantitative systems pharmacology model for the key interleukins involved in Crohn’s disease. J Pharmacol Exp Ther. https://doi.org/10.1124/jpet.119.260539

    Article  PubMed  Google Scholar 

  7. Cheng Y, Thalhauser CJ, Smithline S, Pagidala J, Miladinov M, Vezina HE, Gupta M, Leil TA, Schmidt BJ (2017) QSP toolbox: computational implementation of integrated workflow components for deploying multi-scale mechanistic models. AAPS J. https://doi.org/10.1208/s12248-017-0100-x

    Article  PubMed  Google Scholar 

  8. Duffull S, Gulati A (2020) Potential issues with virtual populations when applied to nonlinear quantitative systems pharmacology models. CPT. https://doi.org/10.1002/psp4.12559

    Article  Google Scholar 

  9. Schmidt BJ, Casey FP, Paterson T, Chan JR (2013) Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis. BMC Bioinform. https://doi.org/10.1186/1471-2105-14-221

    Article  Google Scholar 

  10. Rieger TR, Allen RJ, Bystricky L, Chen Y, Colopy GW, Cui Y, Gonzalez A, Liu Y, White RD, Everett RA, Banks HT, Musante CJ (2018) Improving the generation and selection of virtual populations in quantitative systems pharmacology models. Prog Biophys Mol Biol. https://doi.org/10.1016/j.pbiomolbio.2018.06.002

    Article  PubMed  Google Scholar 

  11. Alexander Stepanov, Galina Lebedeva (2020) Stimulation of erythropoiesis with ESA or blood donation: QSP model, ACoP11,:2688–3953, Vol 2

  12. Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ (2004) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clinic Pharmacology. https://doi.org/10.1177/0091270004268411

    Article  Google Scholar 

  13. Zaninetti L (2017) A left and right truncated lognormal distribution for the stars. arXiv. https://doi.org/10.22606/adap.2017.23005

    Article  Google Scholar 

  14. Zhang X-Y, Trame MN, Lesko LJ, Schmidt S (2015) Sobol sensitivity analysis: a tool to guide the development and evaluation of systems pharmacology models. CPT. https://doi.org/10.1002/psp4.6

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to the two anonymous reviewers for their insightful comments and suggestions which allowed us to significantly improve the results presentation.

Author information

Authors and Affiliations

Authors

Contributions

GK: created methodology and performed all data analysis; OD and GK: discussed and analyzed the results; AS and GL: created model of erythropoiesis. All authors drew the main conclusions and wrote the manuscript.

Corresponding author

Correspondence to Galina Kolesova.

Ethics declarations

Conflict of interest

Authors declare that there are no relevant financial or non-financial competing interests to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 799 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kolesova, G., Stepanov, A., Lebedeva, G. et al. Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis. J Pharmacokinet Pharmacodyn 49, 511–524 (2022). https://doi.org/10.1007/s10928-022-09814-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-022-09814-y

Keywords

Navigation